№2_2022

ONCOLOGY
BULLETIN
OF THE VOLGA REGION Vol. 13, no. 2. 2022
41. Malheiros C.A., Salgueiro L.T., Ilias E.J. Palliative
gastrectomy: is it worth it? // 4 th Intern. Gastric
Cancer Congress. New York, USA, 2001.
42. Ajani J.A. et al. Gastric Cancer, Version 5.
2017, NCCN Clinical Practice Guidelines in
Oncology // J. Natl. Compr. Canc. Netw. —
2016, Oct. — 14 (10). — P. 1286-1312.
43. Guideline Committee of the Korean Gastric
Cancer Association (KGCA), Development
Working Group & Review Panel. Korean Practice
Guideline for Gastric Cancer 2018: an Evidencebased,
Multi-disciplinary Approach // J. Gastric
Cancer. — 2019.
44. Japanese Gastric Cancer Association. Japanese
gastric cancer treatment guidelines 2018
(5 th edition) // Gastric Cancer. — 2021, Jan. — 24 (1).
— P. 1-21. doi: 10.1007/s10120-020-01042-y.
Epub 2020 Feb 14. PMID: 32060757; PMCID:
PMC7790804.
45. Бесова Н.С., Калинин А.Е., Неред С.Н. и др.
Рак желудка. Клинические рекомендации
Ассоциации онкологов России. — М., 2018.
46. Дибиров М.Д. Рак желудка, осложненный
перфорацией и стенозом, в условиях
неотложной хирургии органов брюшной
полости / М.Д. Дибиров, О.Х. Халидов,
А.Е. Закарая // Московский хирургический
журнал. — 2010. — №5 (15). — С. 7-10.
47. Ishiguro T., Fukuchi M., Kumagai Y., et al.
Clinicopathological Study of Perforated Gastric
Cancer Treated with Surgery // Gan To Kagaku
Ryoho. — 2018, Feb. — 45 (2). — P. 309-311.
Japanese. PMID: 29483430.
48. Фролов А.Ю. Хирургическая тактика при
лечении больных перфоративным раком
желудка // Международный медицинский
журнал. — 2013.
49. Gertsch P., Yip S.K., Chow L.W., et al.
Free perforation of gastric carcinoma. Results
of surgical treatment // Arch Surg. — 1995,
Feb. — 130 (2). — P. 177-81. doi: 10.1001/
archsurg.1995.01430020067011. PMID: 7531430.
50. Adachi Y., Mori M., Maehara Y., et al. Surgical
results of perforated gastric carcinoma:
an analysis of 155 Japanese patients //
Am. J. Gastroenterol. — 1997, Mar. — 92 (3). —
P. 516-8. PMID: 9068483.
51. Søreide K., Thorsen K., Søreide J.A. Strategies to
improve the outcome of emergency surgery for
perforated peptic ulcer // Br. J. Surg. — 2014, Jan.
— 101 (1). — P. e51-64. doi: 10.1002/bjs.9368.
Epub 2013 Nov 29. PMID: 24338777.
52. Kawabata H., Hitomi M., Motoi S. Management
of Bleeding from Unresectable Gastric Cancer //
Biomedicines. — 2019, Jul 24. — 7 (3). —
P. 54. doi: 10.3390/biomedicines7030054.
PMID: 31344824; PMCID: PMC6784219.
53. Koh K.H., Kim K., Kwon D.H., et al. The successful
endoscopic hemostasis factors in bleeding
from advanced gastric cancer // Gastric
Cancer. — 2013, Jul. — 16 (3). — P. 397-403.
doi: 10.1007/s10120-012-0200-3. Epub 2012 Oct 5.
PMID: 23053826.
54. Kim Y.I., Choi I.J., Cho S.J., et al. Outcome of
endoscopic therapy for cancer bleeding in
patients with unresectable gastric cancer //
J. Gastroenterol Hepatol. — 2013, Sep. — 28
(9). — P. 1489-95. doi: 10.1111/jgh.12262.
PMID: 23662891.
55. Song Z., Wu Y., Yang J., et al. Progress in the treatment
of advanced gastric cancer // Tumour Biol. —
2017,Jul. — 39 (7). — 1010428317714626 doi:
10.1177/1010428317714626. PMID: 28671042.
56. Kim Y.J., Park J.C., Kim E.H., et al. Hemostatic
powder application for control of acute upper
gastrointestinal bleeding in patients with gastric
malignancy // Endosc. Int. Open. — 2018, Jun. —
6 (6). — P. E700-E705. doi: 10.1055/a-0593-5884.
Epub 2018 May 25. PMID: 29868635; PMCID:
PMC5979193.
57. Tey J. Palliative radiotherapy in symptomatic
locally advanced gastric cancer: A phase II trial //
Cancer Med. — 2019, Apr. — 8 (4). —
P. 1447-1458.
58. Tey J., Choo B.A., Leong C.N., et al.
Clinical outcome of palliative radiotherapy
for locally advanced symptomatic gastric
cancer in the modern era // Medicine
(Baltimore). — 2014 Nov. — 93 (22). — e118.
doi: 10.1097/MD.0000000000000118. PMID:
25396330; PMCID: PMC4616316.
59. Lee Y.H., Lee J.W., Jang H.S. Palliative external
beam radiotherapy for the treatment of tumor
bleeding in inoperable advanced gastric
cancer // BMC Cancer. — 2017, Aug 12. — 17
(1). — 541. doi: 10.1186/s12885-017-3508-x.
Erratum in: BMC Cancer. 2018 Feb 27;18(1):232.
PMID: 28800749; PMCID: PMC5554407.
Literature rewiew 91